E J Hammond, B J Wilder, J Bruni. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » 4-Aminobutyrate Transaminase/antagonists & inhibitorsAction PotentialsAlcohol Oxidoreductases/antagonists & inhibitorsAldehyde Oxidoreductases/antagonists & inhibitorsAnimalsAspartic Acid/metabolismBrain/metabolismCyclic GMP/metabolismDyskinesia, Drug-Induced/drug therapyElectric StimulationElectrophysiologyEpilepsies, Partial/physiopathologyGlycine/metabolismHumansNervous System Diseases/drug therapyNeurons/drug effectsNeurons/physiologySeizures/chemically inducedSeizures/drug therapySeizures/physiopathologySerotonin/metabolismSuccinate-Semialdehyde DehydrogenaseSuccinates/antagonists & inhibitorsValproic Acid/metabolismValproic Acid/pharmacologyValproic Acid/therapeutic usegamma-Aminobutyric Acid/metabolism
Substances: See more » SuccinatesAspartic AcidSerotoningamma-Aminobutyric AcidValproic AcidAlcohol Oxidoreductasesalcohol dehydrogenase (NADP+)Aldehyde OxidoreductasesALDH5A1 protein, humanSuccinate-Semialdehyde Dehydrogenase4-Aminobutyrate TransaminaseCyclic GMPGlycine
Year: 1981 PMID: 6275228 DOI: 10.1016/0024-3205(81)90629-9
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037